CytomX Therapeutics, Inc. (FRA:6C1)
3.444
+0.070 (2.07%)
At close: Dec 5, 2025
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of €575.30 million as of December 5, 2025. Its market cap has increased by 771.97% in one year.
Market Cap
575.30M
Enterprise Value
456.65M
Revenue
96.85M
Ranking
n/a
PE Ratio
24.09
Stock Price
€3.44
Market Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from 399.33M to 575.30M, an increase of 44.07%. That is a compound annual growth rate of 3.66%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.93B |
| Siemens Aktiengesellschaft | 181.89B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |